Alcidion Appointed to NHSX Clinical Communications Procurement Framework

The £3 million framework will allow trusts to procure Alcidion’s Smartpage product without the need for formal tendering.
The £3 million framework will allow trusts to procure Alcidion’s Smartpage product without the need for formal tendering.
Retinal diseases such as diabetic retinopathy (DR), glaucoma, macular degeneration and hypertensive retinopathy are becoming a pandemic. Over a billion people worldwide, and over 75 million people in the US, are at high risk for loss of sight and require an annual retinal check.